»Go to related Japanese page in JPubb

Loading

Press Releases by "Hisamitsu Pharmaceutical Co., Inc."


You may also like to check companies from Hisamitsu Pharmaceutical Co., Inc.'s related industry or location as follows: Pharmaceuticals, Saga

1 - 47 of 47 for your search
Notice concerning the decision of matters relating to acquisition of company’s own shares. (Acquisition of company’s own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)
[ Pharmaceuticals | 2011-03-15]
Transdermal Pain Reliever and Anti-Inflammatory "Mohrus Tape®" (Development Code: KPT-220) Notice Pertaining the Acquisition of Approval to Add the Effects Related to "Pain and Inflammation Relief for Acute Disorders and Symptoms"
[ Pharmaceuticals | 2011-02-23]
Announcement of the acquisition of marketing approval for transdermal long-acting chronic pain "NORSPAN® TAPE" (development code: BTDS)
[ Pharmaceuticals | 2011-02-23]
Noven Pharmaceuticals, Inc. press release : Noven completes acquisition of Daytrana® methylphenidate transdermal system (CII) from Shire
[ Pharmaceuticals | 2010-10-01]
Conduct ofAdditional Clinical Study of KW-2246, a Cancer Pain Drug
[ Pharmaceuticals | 2010-08-27]
Noven Pharmaceuticals, Inc. press release : Noven to acquire Daytrana® methylphenidate transdermal system from Shire
[ Pharmaceuticals | 2010-08-11]
Financial Support to SAGA Heavy Ion Medical Accelerator in Tosu Project
[ Pharmaceuticals | 2010-06-14]
Announcement of Listing of "FENTOS® TAPE," a transdermal, long-acting cancer pain relief patch, on the NHI Drug Price Standard
[ Pharmaceuticals | 2010-06-11]
Notice of Personnel Changes
[ Pharmaceuticals | 2010-05-26]
Notice of Application for Delisting of Stock on Osaka Stock Exchange
[ Pharmaceuticals | 2010-05-26]
Results of Phase III Clinical Trial of HKT-500 in the USA
[ Pharmaceuticals | 2010-04-23]
Hisamitsu Pharmaceutical Announces Marketing Approval of FENTOS® TAPE (Development Code: HFT-290), Transdermal, Long-Acting Cancer Pain Relief Patch
[ Pharmaceuticals | 2010-04-16]
Hisamitsu Announces U.S. Launch of its "Fentanyl Transdermal System" for the Management of Chronic Pain
[ Pharmaceuticals | 2010-03-25]
Revision of Earnings Forecast
[ Pharmaceuticals | 2010-03-24]
Application Filed for Cancer Pain Drug (KW-2246)
[ Pharmaceuticals | 2010-02-25]
Kyowa Hakko Kirin and Hisamitsu entered into a Joint Distribution Agreement on Cancer Pain Drug (Development Code: KW-2246)
[ Pharmaceuticals | 2010-02-01]
Notice concerning acquisition result and acquisition end of companyfs own shares. (Acquisition of companyfs own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)
[ Pharmaceuticals | 2009-12-11]
Investment in Kind to our Subsidiary in the US
[ Pharmaceuticals | 2009-12-03]
Notice concerning the decision of matters relating to acquisition of company's own shares. (Acquisition of company's own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)
[ Pharmaceuticals | 2009-11-12]
Additional Indication (For relief of local pain associated with rheumatoid arthritis) Approved for "MOHRUS Tape," a topical analgesic and anti-inflammatory product (Development Code: KPT-220)
[ Pharmaceuticals | 2009-11-09]
Hisamitsu Announces FDA Approval of its Fentanyl Transdermal System for Management of Chronic Pain (Development code: HFG-512)
[ Pharmaceuticals | 2009-10-19]
Completion of the tender offer for acquisition of shares of Noven Pharmaceuticals, Inc. by our subsidiary
[ Pharmaceuticals | 2009-08-28]
Results of a Phase II clinical study of HTU-520 (terbinafine hydrochloride, patch), atherapeutic agent for tinea unguium
[ Pharmaceuticals | 2009-08-25]
Results of tender offer for acquisition of Noven Pharmaceuticals, Inc. by our subsidiary
[ Pharmaceuticals | 2009-08-21]
Phase II study results of HOB-294 (transdermal oxybutynin hydrochloride) for treatment of overactive bladder
[ Pharmaceuticals | 2009-08-06]
4th Medium-term Management Objectives
[ Pharmaceuticals | 2009-07-27]
The 4th Medium Term Management Plan
[ Pharmaceuticals | 2009-07-27]
Hisamitsu to Acquire US-based Noven Pharmaceuticals Inc.
[ Pharmaceuticals | 2009-07-14]
Acquisition of Noven Pharmaceuticals,Inc.
[ Pharmaceuticals | 2009-07-14]
Modification of Earnings Forecast
[ Pharmaceuticals | 2009-03-24]
Notice concerning acquisition result and acquisition end of company's own shares.
[ Pharmaceuticals | 2009-03-18]
Notice concerning the decision of matters relating to acquisition of company's own shares.
[ Pharmaceuticals | 2009-02-26]
Co-Promotion Agreement of "FOSAMAC"
[ Pharmaceuticals | 2009-01-23]
FY02/2009 Q3 Results Earnings Release Presentation
[ Pharmaceuticals | 2008-12-25]
Application filed for a transdermal patch containing buprenorphine designed to control moderate to severe, chronic lower back and osteoarthritis pain (Development code: BTDS)
[ Pharmaceuticals | 2008-10-31]
FY02/2009 Q2 Results Earnings Pelease Presentation
[ Pharmaceuticals | 2008-10-09]
Notice Regarding Performance Forecasts
[ Pharmaceuticals | 2008-09-25]
FY02/2009 Q1 Results Earnings Pelease Presentation
[ Pharmaceuticals | 2008-07-01]
Application filed for a transdermal absorption-type continuous-action drugto treat cancer pain(Development code: HFT-290)
[ Pharmaceuticals | 2008-06-26]
Conclusion of a joint sales agreement on a transdermal absorption-type continuous-action drug to treat cancer pain(Development code: HFT-290)
[ Pharmaceuticals | 2008-06-18]
FY02/2008 Q4 Results Earnings Pelease Presentation
[ Pharmaceuticals | 2008-04-08]
Information on Countermeasures(Takeover Defenses) for Large-scale Purchases of Hisamitsu Stock
[ Pharmaceuticals | 2008-03-27]
Press Release relating to FDA Approval for SALONPASR PAIN RELEAF PATCH (code: FS-67, topical analgesic product) under NDA
[ Pharmaceuticals | 2008-02-22]
FY02/2008 Q3 Results Earnings Pelease Presentation
[ Pharmaceuticals | 2007-12-27]
Press Release relating to the Exclusive Sales and Distribution Rights for NORSPAN
[ Pharmaceuticals | 2007-08-06]
FINANCIAL REPORT Fiscal 2005
[ Pharmaceuticals | 2005-11-01]
PT.Salonpas Indonesia has changed its company name to PT.Hisamitsu Pharma Indonesia
[ Pharmaceuticals | 2003-07-01]

You may also like to check companies from Hisamitsu Pharmaceutical Co., Inc.'s related industry or location as follows: Pharmaceuticals, Saga

【Hisamitsu Pharmaceutical Co., Inc.】
Stock Exchange
TSE1, NSE1, FSE (Fukuoka)
Industry
Pharmaceuticals
Headquarter Location
Saga
Official Website:
http://www.hisamitsu.co.jp/english/index.html
Official Press-Release Page:
http://www.hisamitsu.co.jp/english/index.html
What's New
Top Searches

Keyword
1. FUJI XEROX SUSTAINABILITY REPORT RECEIVES GOLD AWARD IN SUSTAINABILITY REPORTING AWARDS IN 2012, SPONSORED BY TOYO KEIZAI, INC singapore
2. Starts Operations of Recycling System in South Korea, Australia and New Zealand to Reinforce Global Resource Recycling
3. Fuji Xerox Hong Kong Wins Gold Award at 2011 Hong Kong Awards for Environmental Excellence
4. okyu Land has acquired a luxury nursing home in Kami Yoga, Setagaya Ward, Tokyo
5. FUJI XEROX SUSTAINABILITY REPORT RECEIVES GOLD AWARD IN SUSTAINABILITY REPORTING AWARDS IN 2012, SPONSORED BY TOYO KEIZAI, INC

Company
1. Business Wire Japan
2. Boardwalk Inc.
3. Bank of Japan
4. Tokyo Electric Power Company, Inc.
5. Sharp Corporation

Industry
1. Media & Telecoms
2. Pharmaceuticals
3. Other Financial Sectors
4. Electric Appliances
5. Chemicals

Prefecture
1. Tokyo
2. Osaka
3. Aichi
4. Aomori
5. Kagoshima

Stock Exchange
1. Q-Board
2. FSE (Fukuoka) ALL
3. NSE (Nagoya) ALL
4. SSE (Sapporo) ALL
5. TSE1

Press Conferense Videos
Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays
Sharp Corporation 2012/06/01
More Videos
Latest Press Release Search

Save favorite searches Hot keywords

Fukushima | power supply | cloud | solar
*NOTE: Recommended keywords shown above.
Your Most Recently Viewed Companies
Visit any of the company pages in JPubb, and your most recently viewed companies will automatically show up here.

Erase all This feature:ON How to use
Latest Releases: Hisamitsu Pharmaceutical Co., Inc.
Notice concerning the decision of matters relating to acquisition of company’s own shares. (Acquisition of company’s own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)
2011/03/15
Transdermal Pain Reliever and Anti-Inflammatory "Mohrus Tape®" (Development Code: KPT-220) Notice Pertaining the Acquisition of Approval to Add the Effects Related to "Pain and Inflammation Relief for Acute Disorders and Symptoms"
2011/02/23
Announcement of the acquisition of marketing approval for transdermal long-acting chronic pain "NORSPAN® TAPE" (development code: BTDS)
2011/02/23
Noven Pharmaceuticals, Inc. press release : Noven completes acquisition of Daytrana® methylphenidate transdermal system (CII) from Shire
2010/10/01
Conduct ofAdditional Clinical Study of KW-2246, a Cancer Pain Drug
2010/08/27
Feed
Releases by Prefecture
Hokkaido | Aomori | Iwate | Miyagi | Akita | Yamagata | Fukushima

Ibaraki | Tochigi | Gunma | Saitama | Chiba | Tokyo | Kanagawa

Niigata | Toyama | Ishikawa | Fukui | Yamanashi | Nagano

Gifu | Shizuoka | Aichi | Mie

Shiga | Kyoto | Osaka | Hyogo | Nara | Wakayama

Tottori | Shimane | Okayama | Hiroshima | Yamaguchi

Tokushima | Kagawa | Ehime | Kochi

Fukuoka | Saga | Nagasaki | Kumamoto | Oita | Miyazaki | Kagoshima | Okinawa
Releases by Stock Exchange
TSE (Tokyo) All | TSE1 | TSE2 | Mothers

OSE (Osaka) All | OSE1 | OSE2 | JASDAQ Standard | JASDAQ Growth

NSE (Nagoya) All | NSE1 | NSE2 | Centrex | NSE-only

SSE (Sapporo) All | Ambitious | SSE-only

FSE (Fukuoka) All | Q-Board | FSE-only
Press Release Search
Company
Industry
Prefecture
Stock Exchange
Date
(yyyy/mm/dd)		 //～
//
Listed or Non-listed
*NOTE: Please input only items to be specified.
*NOTE: The "date" here means the one on which a press release is uploaded on this website. So it isn't necessarily the same as its official announcement date.
Company Search
Company
Industry
Prefecture
Stock Exchange
Listed or Non-listed
*NOTE: Please input only items to be specified.